UBS Maintains Neutral on Acuren, Lowers Price Target to $11
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
UBS analyst Joshua Chan maintains Acuren (NYSE:TIC) with a Neutral and lowers the price target from $11.5 to $11.
UBS analyst Joshua Chan maintains Acuren (NYSE:TIC) with a Neutral and lowers the price target from $11.5 to $11.